Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 5, 2014, Pages 309-315

  Yongvanit, Puangrat ^a   Pinlaor, Somchai ^a   Loilome, Watcharin ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Chemopreventive agents; Cholangiocarcinoma; Opisthorchis viverrini; Periductal fibrosis; Risk markers

Indexed keywords

BIOLOGICAL MARKER; COLLAGENASE 3; CURCUMIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIMETHYLNITROSAMINE; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MARCKS PROTEIN; MATRILYSIN; MATRIX METALLOPROTEINASE 14; PRAZIQUANTEL; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; DNA ADDUCT; FASCIOLA HEPATICA; GENE EXPRESSION; HUMAN; NONHUMAN; OPISTHORCHIASIS; RISK ASSESSMENT; THAILAND; ANIMAL; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMPLICATION; INTRAHEPATIC BILE DUCT; OPISTHORCHIS; PARASITOLOGY; PROCEDURES; RISK FACTOR;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; CHEMOPREVENTION; CHOLANGIOCARCINOMA; HUMANS; OPISTHORCHIASIS; OPISTHORCHIS; RISK FACTORS; THAILAND;

EID: 84898989652     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.63     Document Type: Article

References (63)

1. Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Malone WF, et al. Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl. 1996; 25: 1-14. (Pubitemid 27078305)
2. Bell K,. Biomarkers, the molecular gaze and the transformation of cancer survivorship. Biosocieties. 2013; 8: 124-143.
3. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward. Clin Cancer Res. 2006; 12: 3661-3697. (Pubitemid 44000248)
4. Steele VE, Kelloff GJ,. Development of cancer chemopreventive drugs based on mechanistic approaches. Mutat Res. 2005; 591: 16-23. (Pubitemid 41654836)
5. Vogelstein B,. Genetic testings for cancer: the surgeon's critical role. Familial colon cancer. J Am Coll Surg. 1999; 188: 74-79.
6. Blechacz B, Gores GJ,. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008; 48: 308-321. (Pubitemid 351975555)
7. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer. 1994; 59: 505-509. (Pubitemid 24357275)
8. Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S,. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res. 1978; 38: 4634-4639. (Pubitemid 9065143)
9. IARC. Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus, Clornorchis sinensis). IARC monographs on the Evaluation of Carcinogenic Risks to Human. Lyon: International Agency for Research on Cancer; 1994. 61: p. 121-175.
10. IARC. A review of human carcinogens: Opisthorchis viverrini and Clonorchis sinensis. IARC Monogr Eval Carcinog Risks Hum. 2012; 100B: 341-370.
11. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int. 2012; 61: 10-16.
12. Jongsuksuntigul P, Imsomboon T,. Opisthorchiasis control in Thailand. Acta Trop. 2003; 88: 229-232. (Pubitemid 37377818)
13. Saowakontha S, Pipitgool V, Pariyanonda S, Tesana S, Rojsathaporn K, Intarakhao C,. Field trials in the control of Opisthorchis viverrini with an integrated programme in endemic areas of northeast Thailand. Parasitology. 1993; 106 (Pt 3): 283-288.
14. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM,. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health. 2004; 9: 588-594. (Pubitemid 38657284)
15. Green A, Uttaravichien T, Bhudhisawasdi V, Chartbanchachai W, Elkins DB, Marieng EO, et al. Cholangiocarcinoma in north east Thailand. A hospital-based study. Trop Geogr Med. 1991; 43: 193-198.
16. Yongvanit P, Pinlaor S, Bartsch H,. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int. 2012; 61: 130-135.
17. Pinlaor S, Hiraku Y, Ma N, Yongvanit P, Semba R, Oikawa S, et al. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide. 2004; 11: 175-183. (Pubitemid 39371095)
18. Thanan R, Murata M, Pinlaor S, Sithithaworn P, Khuntikeo N, Tangkanakul W, et al. Urinary 8-oxo-7,8-dihydro-2-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis. Cancer Epidemiol Biomarkers Prev. 2008; 17: 518-524. (Pubitemid 351469200)
19. Pinlaor S, Ma N, Hiraku Y, Yongvanit P, Semba R, Oikawa S, et al. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis. 2004; 25: 1535-1542. (Pubitemid 39162719)
20. Pinlaor S, Sripa B, Sithithaworn P, Yongvanit P,. Hepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverrini. Exp Parasitol. 2004; 108: 32-39. (Pubitemid 39445853)
21. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Bartsch H, Yongvanit P,. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat Res. 2010; 691: 9-16.
22. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Nair J, Bartsch H, Yongvanit P,. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel. Cancer Epidemiol Biomarkers Prev. 2010; 19: 310-318.
23. Dechakhamphu S, Yongvanit P, Nair J, Pinlaor S, Sitthithaworn P, Bartsch H,. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1658-1664.
24. Jusakul A, Loilome W, Namwat N, Haigh WG, Kuver R, Dechakhamphu S, et al. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Mutat Res. 2012; 731: 48-57.
25. Jusakul A, Loilome W, Namwat N, Techasen A, Kuver R, Ioannou G, et al. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. J Steroid Biochem Mol Biol. 2013; 138: 368-375.
26. Thanan R, Oikawa S, Yongvanit P, Hiraku Y, Ma N, Pinlaor S, et al. Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma. Free Radic Biol Med. 2012; 52: 1465-1472.
27. Jamnongkan W, Techasen A, Thanan R, Duenngai K, Sithithaworn P, Mairiang E, et al. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Tumour Biol. 2013; 34: 695-704.
28. Loilome W, Juntana S, Namwat N, Bhudhisawasdi V, Puapairoj A, Sripa B, et al. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. Int J Cancer. 2011; 129: 34-44.
29. Loilome W, Yongvanit P, Wongkham C, Tepsiri N, Sripa B, Sithithaworn P, et al. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. Mol Carcinog. 2006; 45: 279-287.
30. Loilome W, Yooyuen S, Namwat N, Sithithaworn P, Puapairoj A, Kano J, et al. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Tumour Biol. 2012; 33: 2289-2298.
31. Techasen A, Loilome W, Namwat N, Duenngai K, Cha'on U, Thanan R, et al. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. Parasitol Int. 2012; 61: 140-144.
32. Techasen A, Loilome W, Namwat N, Takahashi E, Sugihara E, Puapairoj A, et al. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Cancer Sci. 2010; 101: 658-665.
33. Chusorn P, Namwat N, Loilome W, Techasen A, Pairojkul C, Khuntikeo N, et al. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumour Biol. 2013; 34: 1579-1588.
34. Bhamarapravati N, Thammavit W, Vajrasthira S,. Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am J Trop Med Hyg. 1978; 27: 787-794. (Pubitemid 8398085)
35. Flavell DJ, Flavell SU,. Opisthorchis viverrini: pathogenesis of infection in immunodeprived hamsters. Parasite Immunol. 1986; 8: 455-466. (Pubitemid 16016447)
36. Prakobwong S, Pinlaor S, Yongvanit P, Sithithaworn P, Pairojkul C, Hiraku Y,. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol. 2009; 39: 825-835.
37. Prakobwong S, Yongvanit P, Hiraku Y, Pairojkul C, Sithithaworn P, Pinlaor P, et al. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Int J Cancer. 2010; 127: 2576-2587.
38. Riganti M, Pungpak S, Punpoowong B, Bunnag D, Harinasuta T,. Human pathology of Opisthorchis viverrini infection: a comparison of adults and children. Southeast Asian J Trop Med Public Health. 1989; 20: 95-100.
39. Sripa B, Haswell-Elkins MR, Sinawat P,. Histological analysis of gallbladder diseases in relation to opisthorchiasis in endemic areas of Thailand. Acta Trop. 2003; 88: 239-246. (Pubitemid 37377820)
40. Elkins DB, Mairiang E, Sithithaworn P, Mairiang P, Chaiyakum J, Chamadol N, et al. Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans. Am J Trop Med Hyg. 1996; 55: 295-301. (Pubitemid 26321835)
41. Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD,. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013; 145: 521-536.
42. Sripa B, Thinkhamrop B, Mairiang E, Laha T, Kaewkes S, Sithithaworn P, et al. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis. 2012; 6: e1654.
43. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, et al. The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol. 2012; 28: 395-407.
44. Wynn TA,. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214: 199-210. (Pubitemid 351160157)
45. Hutadilok N, Ruenwongsa P,. Liver collagen turnover in hamsters during infection by the human liver fluke, Opisthorchis viverrini. Mol Biochem Parasitol. 1983; 8: 71-77. (Pubitemid 13136824)
46. Chotigeat W, Ruenwongsa P,. Types of collagen in Opisthorchis viverrini infected hamster liver. Mol Biochem Parasitol. 1986; 18: 377-387. (Pubitemid 16158492)
47. Khoontawad J, Laothong U, Roytrakul S, Pinlaor P, Mulvenna J, Wongkham C, et al. Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection. PLoS ONE. 2012; 7: e45460.
48. Akai PS, Pungpak S, Chaicumpa W, Kitikoon V, Ruangkunaporn Y, Bunnag D, et al. Serum antibody responses in opisthorchiasis. Int J Parasitol. 1995; 25: 971-973.
49. Khoontawad J, Wongkham C, Hiraku Y, Yongvanit P, Prakobwong S, Boonmars T, et al. Proteomic identification of peroxiredoxin 6 for host defence against Opisthorchis viverrini infection. Parasite Immunol. 2010; 32: 314-323.
50. Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA,. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res. 2006; 66: 6622-6627. (Pubitemid 44085618)
51. Prakobwong S, Charoensuk L, Hiraku Y, Pinlaor P, Pairojkul C, Mairiang E, et al. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma. Int J Cancer. 2012; 131: E416-424.
52. Pinlaor P, Pongsamart P, Hongsrichan N, Sangka A, Srilunchang T, Mairiang E, et al. Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma. Parasitol Int. 2012; 61: 212-216.
53. Pinlaor S, Prakobwong S, Hiraku Y, Kaewsamut B, Dechakhamphu S, Boonmars T, et al. Oxidative and nitrative stress in Opisthorchis viverrini-infected hamsters: an indirect effect after praziquantel treatment. Am J Trop Med Hyg. 2008; 78: 564-573. (Pubitemid 351845158)
54. Riganti M, Pungpak S, Sachakul V, Bunnag D, Harinasuta T,. Opisthorchis viverrini eggs and adult flukes as nidus and composition of gallstones. Southeast Asian J Trop Med Public Health. 1988; 19: 633-636.
55. Laothong U, Pinlaor P, Hiraku Y, Boonsiri P, Prakobwong S, Khoontawad J, et al. Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters. J Pineal Res. 2010; 49: 271-282.
56. Pinlaor S, Yongvanit P, Prakobwong S, Kaewsamut B, Khoontawad J, Pinlaor P, et al. Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini. Mol Nutr Food Res. 2009; 53: 1316-1328.
57. Pinlaor S, Prakobwong S, Hiraku Y, Pinlaor P, Laothong U, Yongvanit P,. Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment. Eur J Pharmacol. 2010; 638: 134-141.
58. Charoensuk L, Pinlaor P, Prakobwong S, Hiraku Y, Laothong U, Ruangjirachuporn W, et al. Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Int J Parasitol. 2011; 41: 615-626.
59. Boonjaraspinyo S, Boonmars T, Aromdee C, Srisawangwong T, Kaewsamut B, Pinlaor S, et al. Turmeric reduces inflammatory cells in hamster opisthorchiasis. Parasitol Res. 2009; 105: 1459-1463.
60. Wonkchalee O, Boonmars T, Aromdee C, Laummaunwai P, Khunkitti W, Vaeteewoottacharn K, et al. Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis. Parasitol Res. 2012; 111: 353-359.
61. Prakobwong S, Khoontawad J, Yongvanit P, Pairojkul C, Hiraku Y, Sithithaworn P, et al. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int J Cancer. 2011; 129: 88-100.
62. Laothong U, Pinlaor P, Boonsiri P, Pairojkul C, Priprem A, Pratheepawanit JN, et al. Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters. J Pineal Res. 2013; 55: 257-266.
63. Pinlaor S, Prakobwong S, Boonmars T, Wongkham C, Pinlaor P, Hiraku Y,. Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection. Acta Trop. 2009; 111: 181-191.